Global Proton Therapy Market & Forecast 2010-2024 - Patients Treated at Proton Therapy Centers & Reimbursement Policies - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Oct 8, 2018--The “Global Proton Therapy Market & Forecast (12 Countries Market Data), Patients Treated at Proton Therapy Centers, Reimbursement Policies ” report has been added to ResearchAndMarkets.com’s offering.
The global proton therapy market will surpass US$ 18 Billion by 2018
According to this analysis, the global proton therapy market will be growing at a rapid pace due to a rising number of proton therapy centers across the world. In addition, there are number of proton therapy centers in the construction and planning phases in several countries like China, United Kingdom, Germany, France, Japan, United States, Korea and Switzerland. The United States is the hub of proton therapy, holding more than 40 percent proton therapy center till 2018.
The United Kingdom is best known for healthcare facilities, but the number of proton therapy centers is very few as per the demand, so patients from the United Kingdom must go to the US for treatment. According to our research, the UK is likely to launch five highly advanced multi-room proton therapy centers owned by the NHS and Private Players during the forecast period.
In this report, a special chapter is provided about Proton Therapy in Europe, covering eight countries: the United Kingdom, Switzerland, Russia, Germany, France, Italy, Sweden and Poland. This report covers a detailed investigation of proton therapy by market & forecast by each countries, volume of patients treated and forecast by each country, volume of patients treated by each proton therapy center located in the country. In addition we have also covered the number of proton therapy center in operational state, under-construction phase and planning stage by each country. These reports also talk about dimension and structure of reimbursement policies.
Global Proton Therapy - Company Analysis 2010-2024Elekta IBA Varian Medical Systems
Driving FactorsTechnology Advancement Rising Prevalence of Cancer Patients Globally
ChallengesRequires Huge Investment Operations Challenges
For more information about this report visit https://www.researchandmarkets.com/research/jngc67/global_proton?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181008005379/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Nuclear Medicine and Radiopharmacology
INDUSTRY KEYWORD: HEALTH ONCOLOGY GENERAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 10/08/2018 07:49 AM/DISC: 10/08/2018 07:49 AM